Jiang S - Search Results

1

Vaccine design for severe acute respiratory syndrome coronavirus.

He Y, Jiang S. He Y, et al. Among authors: jiang s. Viral Immunol. 2005;18(2):327-32. doi: 10.1089/vim.2005.18.327. Viral Immunol. 2005. PMID: 16035944 Review.

2

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S. Liu S, et al. Among authors: jiang s. Lancet. 2004 Mar 20;363(9413):938-47. doi: 10.1016/S0140-6736(04)15788-7. Lancet. 2004. PMID: 15043961 Free PMC article.

3

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S. He Y, et al. Among authors: jiang s. J Immunol. 2004 Sep 15;173(6):4050-7. doi: 10.4049/jimmunol.173.6.4050. J Immunol. 2004. PMID: 15356154

4

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. He Y, et al. Among authors: jiang s. Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81. doi: 10.1016/j.bbrc.2004.09.106. Biochem Biophys Res Commun. 2004. PMID: 15474494 Free PMC article.

5

N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.

Jiang S, Lu H, Liu S, Zhao Q, He Y, Debnath AK. Jiang S, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4349-59. doi: 10.1128/AAC.48.11.4349-4359.2004. Antimicrob Agents Chemother. 2004. PMID: 15504864 Free PMC article.

6

Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus.

He Y, Zhou Y, Wu H, Kou Z, Liu S, Jiang S. He Y, et al. Among authors: jiang s. J Clin Microbiol. 2004 Nov;42(11):5309-14. doi: 10.1128/JCM.42.11.5309-5314.2004. J Clin Microbiol. 2004. PMID: 15528730 Free PMC article.

7

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.

He Y, Zhou Y, Siddiqui P, Jiang S. He Y, et al. Among authors: jiang s. Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52. doi: 10.1016/j.bbrc.2004.10.052. Biochem Biophys Res Commun. 2004. PMID: 15530413 Free PMC article.

8

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.

He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. He Y, et al. Among authors: jiang s. Virology. 2005 Mar 30;334(1):74-82. doi: 10.1016/j.virol.2005.01.034. Virology. 2005. PMID: 15749124 Free PMC article.

9

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.

He Y, Lu H, Siddiqui P, Zhou Y, Jiang S. He Y, et al. Among authors: jiang s. J Immunol. 2005 Apr 15;174(8):4908-15. doi: 10.4049/jimmunol.174.8.4908. J Immunol. 2005. PMID: 15814718

10

Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.

Liu S, Lu H, Zhao Q, He Y, Niu J, Debnath AK, Wu S, Jiang S. Liu S, et al. Among authors: jiang s. Biochim Biophys Acta. 2005 May 25;1723(1-3):270-81. doi: 10.1016/j.bbagen.2005.02.012. Epub 2005 Mar 24. Biochim Biophys Acta. 2005. PMID: 15823507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,461 results

Search Page

Filters